Checkout
Cart: £0.00 - (0 items )

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market  While $5.7 billion was invested in companies developing cellular and genetic therapies, and with 800 clinical trials initiated worldwide and the first two CAR-T cell therapies expected to launch into market later this year, businesses still say the ability to get these […]

Read More

Back to top